MYGN Financials
Myriad Genetics Inc - Financial statements & key metrics
Stock Price
$3.22
Market Cap
$413.68M
P/E Ratio
-2.3
EPS
$-4.35
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$837.60M
Gross Profit
-
Operating Income
-
Net Income
$-127.30M
EPS (Diluted)
$-1.41
Balance Sheet Highlights
Total Assets
$1.03B
Total Liabilities
$326.50M
Shareholders Equity
-
Cash & Equivalents
$102.40M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-8.70M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
-11.3%
Net Margin
-48.5%
ROE
-72.5%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is MYGN revenue?
MYGN's most recent quarterly revenue was $837.60M. Annual revenue can be calculated by summing the four most recent quarters.
Is MYGN profitable?
MYGN reported a loss of $127.30M in the most recent quarter. The net profit margin is -48.5%.
What is MYGN market cap?
MYGN has a market capitalization of $413.68M, making it a small-cap stock.
Does MYGN have debt?
View MYGN's balance sheet for debt information.
What is MYGN cash flow?
Cash flow data is available in the full financial statements.